Woodline Partners LP Eli Lilly & CO Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Woodline Partners LP holds 114,427 shares of LLY stock, worth $87.9 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

114,427

Previous 284,589 59.79%

Holding current value

$87.9 Million

Previous $258 Million 60.66%

% of portfolio

0.92%

Previous 2.58%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $131 Million - $163 Million	-170,162 Reduced 59.79%	114,427 $101 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $24.1 Million - $30.2 Million	-33,235 Reduced 10.46%	284,589 $258 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $445,926 - $596,586	753 Added 0.24%	317,824 $247 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $23.7 Million - $27.9 Million	45,071 Added 16.57%	317,071 $185 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $9.93 Million - $13.7 Million	-22,853 Reduced 7.75%	272,000 $146 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $65.8 Million - $88 Million	187,624 Added 174.98%	294,853 $138 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $50.8 Million - $59.1 Million	-157,870 Reduced 59.55%	107,229 $39.2 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $68.5 Million - $78 Million	-230,904 Reduced 46.55%	265,099 $85.7 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $104 Million - $122 Million	373,668 Added 305.45%	496,003 $161 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $62.2 Million - $77.3 Million	-264,966 Reduced 68.41%	122,335 $35 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $16 Million - $19.9 Million	71,198 Added 22.52%	387,301 $107 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $35.1 Million - $43.2 Million	158,412 Added 100.46%	316,103 $73 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $7.59 Million - $9.82 Million	42,045 Added 36.36%	157,691 $36.2 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $48.3 Million - $62.6 Million	-294,204 Reduced 71.78%	115,646 $21.6 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $44.6 Million - $59 Million	341,943 Added 503.55%	409,850 $69.2 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $28.5 Million - $33 Million	-195,122 Reduced 74.18%	67,907 $10.1 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $7.18 Million - $8.64 Million	52,636 Added 25.02%	263,029 $43.2 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $1.28 Million - $1.59 Million	-10,773 Reduced 4.87%	210,393 $29.2 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $23.6 Million - $29.3 Million	221,166 New	221,166 $29.1 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Eli Lilly & CO Transaction History